Daniel Schuppmann, LL.M.
Senior Associate
- Intellectual Property
- Life Sciences
- Commercial Agreements
- Technology & Data Protection
Daniel is a senior associate at NEUWERK with a focus on intellectual property and information technology law, commercial matters and agreements within the life science industry.
He has a particular focus in the field of licensing and commercialization of IP rights. In addition, he advises clients on technology and data protection law as well as in the context of M&A transactions, carve-outs and commercial agreements of all kinds.
Daniel has extensive experience in assisting biotech and pharma clients with the protection and licensing of their technologies, the negotiation of research partnerships and all questions relating to the development, manufacture and distribution of pharmaceutical products.
CV
Daniel studied law at Bucerius Law School in Hamburg and at Singapore Management University in Singapore. He also completed the LL.M. program "International Technology Law" at the Vrije Universiteit in Amsterdam, with a focus on legal issues relating to the use of artificial intelligence in the medical sector.
Daniel completed his legal clerkship at the Hanseatic Higher Regional Court in Hamburg, during which he worked for Hogan Lovells in the practice group "IP, Media & Technology" as well as at a chamber at the Regional Court of Hamburg specialized in intellectual property law. He further worked for the South Korean law firm Kim & Chang in Seoul and NEUWERK in his current areas of practice.
Recent work
The University Hospital of Cologne on a licensing and cooperation agreement with BioNTech for research into new approaches against HIV
A Berlin-based biotechnology company on a licensing and distribution collaboration in the field of severe bacterial infections with a U.S. pharmaceutical company
A leading European pharmaceutical company on manufacturing and distribution issues in connection with an envisaged carve-out and acquisition of a comprehensive product portfolio from a globally operating pharma company
A Hamburg-based leading developer of software solutions in the field of advanced real-time 3D graphic (e.g. for Olympic Games or the Super Bowl) in providing ongoing legal advice on all IT contracts
A Hamburg-based eHealth specialist service provider for patient monitoring services in intensive care units, in the preparation of all contracts related to the establishment of the central IT systems and for the conclusion of outsourcing and service collaborations with several hospital groups
A leading European protein engineering company on multiple commercial and IP-related agreements, including a global, high-value R&D-collaboration and licensing arrangement
An international chemical group, in the complete data protection reorganization of the group after a carve-out
A German pharmaceutical company on an envisaged divestiture and related license and supply agreement regarding one of its best-selling products to a global pharmaceutical company for the Spanish market
Publications
Regulierung von KI durch EU-Gesetzgebung. Was erwartet die Life-Sciences-Industrie durch die geplante KI-Verordnung?, Plattform Life Sciences, 3/2022
Rechtliche Fragen der Kommerzialisierung von KI-Systemen, Plattform Life Sciences, 2/2021
Languages
German
English